Sort
51,593 grants matching “hepatitis”
The role of cancer stem cells in liver cancer heterogeneity and subtypes
$797,101Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Molecular signatures for liver cancer diagnosis and treatment stratification
$797,101Xin Wang · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
MR-Image Guided Focused Ultrasound for Treatment of Liver and Renal Cancer
$797,017Kim Butts Pauly · Stanford University · R01 · FY2010 · CA
Biospecimen Analysis
$796,905Suman Ranjan Das · Vanderbilt University Medical Center · U54 · FY2025 · AG
Colorado Hepatitis C Cooperative Research Center
$796,875Hugo R Rosen · University Of Colorado Denver · U19 · FY2010 · AI
Human Genetic determinants of HBV recovery
$796,842David L Thomas · Johns Hopkins University · R01 · FY2022 · AI
URSODIOL-METHOTREXATE FOR PRIMARY BILIARY CIRRHOSIS
$796,705University Of Texas Sw Med Ctr/Dallas · R01 · FY2000 · DK
The Long-Acting/Extended Release Antiretroviral Resource Program (LEAP)
$796,698Charles W. Flexner · Johns Hopkins University · R24 · FY2024 · AI
Structure And Assembly Of The Hepatitis B Nucleocapsid Protein
$796,218Paul T Wingfield · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2013 · AR
Anti-norovirus protease inhibitors for immunocompromised patients
$796,178Raymond F. Schinazi · Emory University · R01 · FY2023 · AI
Atlanta Center for the Childhood Liver Disease Research Network (ChiLDReN)
$796,000Saul Joseph Karpen · Emory University · U01 · FY2020 · DK
Natural History of Hepatitis C Infection in HIV Disease
$795,957Deborah Cotton · Boston University Medical Campus · R01 · FY2006 · DA
Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR
$795,711John Nagi Kheir · Boston Children'S Hospital · R33 · FY2023 · HL
Immunology of Acute and Chronic Viral Hepatitis
$795,677Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Analysis and Modulation of Virus-Host Interaction in Infections of the Liver
$795,677Barbara Rehermann · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2016 · DK
Clinical & Immunological Study of Treatment Withdrawal in E-Ag Negative Hepatitis B
$795,453Stewart Cooper · California Pacific Med Ctr Res Institute · R01 · FY2016 · DK
Defining functional humoral correlates of immunity to guide vaccine design
$795,292Facundo Damian Batista · Massachusetts General Hospital · R01 · FY2023 · AI
Immune Control and Evasion during Acute HCV Infection
$795,032Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2012 · AI
Immune Control and Evasion during Acute HCV Infection
$795,032Georg Michael Lauer · Massachusetts General Hospital · U19 · FY2014 · AI
Animal Model to study heterogeneous outcomes of HCV Infection and Pathogenesis
$794,961Amit Kapoor · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · AI
Control of Viral Pathogenesis by Regulation of 2-5A Levels
$794,957Susan R. Weiss · University Of Pennsylvania · R01 · FY2021 · AI
Effects of early life Triclosan exposure through lactation on the gut-liver axis and its implications in the development of steatotic liver disease in adults
$794,841Robert H Tukey · University Of California, San Diego · R01 · FY2025 · ES
Neutralizing antibody responses during natural control of acute hepatitis B with and without HIV-1 coinfection
$794,719Justin Richard Bailey · Johns Hopkins University · R01 · FY2023 · AI
Novel Drugs to Treat Urinary Incontinence
$794,658Jan Chen · Glsynthesis, Inc. · R44 · FY2008 · AG
U of Colorado Center for AIDS Research
$794,362Thomas B Campbell · University Of Colorado Denver · P30 · FY2008 · AI